Back to search

Article

Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severity

2022-04-21

Abstract excerpt

<h4>ABSTRACT</h4> Venous thromboembolism (VTE), comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based tools for VTE diagnosis and risk prediction. We used multiplex proteomics profiling to screen plasma from patients with suspected...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3acedfac-3eaf-5430-a355-803a5fd25b9d
DOI
10.1101/2022.04.20.22274046
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severityDOI 10.1101/2022.04.20.22274046
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolismSemantic proximity
Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism.Semantic proximity
Genome-wide cross-trait analysis and Mendelian randomization reveal a shared genetic etiology and causality between COVID-19 and venous thromboembolismSemantic proximity
Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization studySemantic proximity
Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.Semantic proximity
Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and ThromboembolismSemantic proximity
Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.Semantic proximity
Identification of potential biomarkers of venous thromboembolism in patients with COVID-19 via an integrated bioinformatic-based studySemantic proximity
Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.Semantic proximity
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsSemantic proximity
Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis.Semantic proximity
Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolismSemantic proximity
Select a neighboring publication to make it the new centre.